ASEM documentary overview
Official Canadian Paediatric Society document (2021) on “Guidelines for surfactant replacement therapy in neonates”. Abstract Surfactant replacement therapy (SRT) plays a pivotal role in the management of neonates with respiratory distress syndrome (RDS) because it improves survival and reduces respiratory morbidities. With the increasing use of non-invasive ventilation as the primary mode of respiratory support for preterm infants at delivery, prophylactic surfactant is no longer beneficial. For infants with worsening RDS, early r.
This overview helps you identify the document. Always consult the current official publication for clinical recommendations.
Official document